INmune Bio, Inc. (INMB)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 221.32M |
| Enterprise value | 195.91M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.30k |
| Price/book (mrq) | 5.80 |
| Enterprise value/revenue | 1.26k |
| Enterprise value/EBITDA | -6.59 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.95 |
| 52-week change 3 | 36.92% |
| S&P500 52-week change 3 | 24.49% |
| 52-week high 3 | 14.74 |
| 52-week low 3 | 6.50 |
| 50-day moving average 3 | 11.22 |
| 200-day moving average 3 | 9.67 |
Share statistics
| Avg vol (3-month) 3 | 114.4k |
| Avg vol (10-day) 3 | 237.28k |
| Shares outstanding 5 | 19.76M |
| Implied shares outstanding 6 | 20.41M |
| Float 8 | 12.21M |
| % held by insiders 1 | 32.20% |
| % held by institutions 1 | 12.41% |
| Shares short (15 Apr 2024) 4 | 1.5M |
| Short ratio (15 Apr 2024) 4 | 14.76 |
| Short % of float (15 Apr 2024) 4 | 12.60% |
| Short % of shares outstanding (15 Apr 2024) 4 | 8.25% |
| Shares short (prior month 15 Mar 2024) 4 | 1.44M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -29,925.00% |
Management effectiveness
| Return on assets (ttm) | -26.79% |
| Return on equity (ttm) | -61.09% |
Income statement
| Revenue (ttm) | 155k |
| Revenue per share (ttm) | 0.01 |
| Quarterly revenue growth (yoy) | -71.10% |
| Gross profit (ttm) | N/A |
| EBITDA | N/A |
| Net income avi to common (ttm) | -30.01M |
| Diluted EPS (ttm) | -1.62 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 35.85M |
| Total cash per share (mrq) | 1.99 |
| Total debt (mrq) | 10.44M |
| Total debt/equity (mrq) | 27.37% |
| Current ratio (mrq) | 2.16 |
| Book value per share (mrq) | 2.08 |
Cash flow statement
| Operating cash flow (ttm) | -11.98M |
| Levered free cash flow (ttm) | -1.4M |
© 2024 Yahoo. All rights reserved.